Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07853625) titled 'Sacubitril/Valsartan Versus Valsartan Alone on Left Atrial Volume Index in Hypertensive Patients' on Sept. 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: University of Health Sciences Lahore
Condition:
Hypertension
Left Ventricular Diastolic Dysfunction
Essential (Primary) Hypertension
Intervention:
Other: Sacubitril / Valsartan
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 1, 2026
Target Sample Size: 102
To know more, visit https://cli...